搜索临床试验以:Concomitant Boost Radiation
总计11542个结果
-
Jiangsu HengRui Medicine Co., Ltd.Sun Yat-sen University完全的
-
IRCCS Azienda Ospedaliero-Universitaria di Bologna未知
-
Children's Oncology GroupNational Cancer Institute (NCI)完全的
-
Samsung Medical CenterKorean Radiation Oncology Group未知
-
Sanofi Pasteur, a Sanofi Company完全的
-
University of Erlangen-Nürnberg Medical School未知
-
Siriwan Tangjitgamol, MDPrince of Songkla University; National Research Council of Thailand; Chiang Mai University; Navamindradhiraj... 和其他合作者未知
-
Xue Xiaoying完全的
-
Vanderbilt-Ingram Cancer CenterNational Cancer Institute (NCI)完全的
-
British Columbia Cancer Agency撤销
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI)完全的
-
Tianjin Medical University Cancer Institute and...未知
-
IRCCS Azienda Ospedaliero-Universitaria di Bologna完全的
-
AHS Cancer Control AlbertaCross Cancer Institute完全的
-
Memorial Sloan Kettering Cancer Center完全的黑色素瘤 | 肉瘤 | 宫颈癌 | 乳腺癌 | 胰腺癌 | 肺癌 | 直肠癌 | 前列腺癌 | 膀胱癌 | 结肠癌 | 脑转移 | 睾丸癌 | 癌症美国
-
University Health Network, TorontoPrincess Margaret Hospital, Canada完全的
-
Cancer Institute and Hospital, Chinese Academy...Sanofi; Chia Tai Tianqing Pharmaceutical Group Co., Ltd.未知
-
Dana-Farber Cancer InstituteBrigham and Women's Hospital终止
-
Hui Lin未知Lung Adenocarcinoma Patients With Postoperative in pN2中国
-
Virginia Commonwealth UniversityNational Cancer Institute (NCI)撤销IIIA期非小细胞肺癌 | IIIB 期非小细胞肺癌 | 鳞状细胞肺癌 | 肺腺癌 | 大细胞肺癌 | IIA期非小细胞肺癌 | IIB 期非小细胞肺癌
-
Samsung Medical CenterAsan Medical Center; Yonsei University; Seoul National University; Chonnam National University完全的
-
University of TorontoFerring Pharmaceuticals终止
-
Merck KGaA, Darmstadt, Germany完全的